Kunjian Lei
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Advancing targeted protein degradation: pLIRTAC's role in glioma and CAR-T cell therapy.
Journal: Autophagy
Published: May 04, 2026
Integrated pan-cancer analysis and experimental validation reveal that syndecan-1 drives glioblastoma pathogenesis and associates with immune infiltration.
Journal: Discover oncology
Published: December 19, 2025
Engineered targeted enhancement of translation in mammalian cell.
Journal: BMC biology
Published: August 28, 2025
Phosphatidylcholine-derived carriers facilitate brain tumor delivery and enhance glioblastoma therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 22, 2025
Clathrin mediated endocytosis targeting chimera for targeted membrane proteins degradation and enhance CAR-T cell anti-tumor therapy.
Journal: Theranostics
Published: March 19, 2025
Mechanisms underlining R-loop biology and implications for human disease.
Journal: Frontiers in cell and developmental biology
Published: December 01, 2024
Endosome-microautophagy targeting chimera (eMIATAC) for targeted proteins degradation and enhance CAR-T cell anti-tumor therapy.
Journal: Theranostics
Published: May 17, 2024
The link between neutrophils, NETs, and NLRP3 inflammasomes: The dual effect of CD177 and its therapeutic potential in acute respiratory distress syndrome/acute lung injury.
Journal: Biomolecules & biomedicine
Published: November 27, 2023
Comprehensive analyses of m1A regulator-mediated modification patterns determining prognosis in lower-grade glioma (running title: m1A in LGG).
Journal: Heliyon
Published: October 11, 2023
Aberrant RBMX expression is relevant for cancer prognosis and immunotherapy response.
Journal: Aging
Published: July 05, 2023
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 20, 2023
MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting CCND1
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: June 08, 2022
Last Updated: 09/26/2026